Comparison of ALK Immunohistochemical staining and fluorescence <i>in situ</i> hybridization analysis results. (n = 27).
<p>AJCC, American Joint Committee on Cancer; ALK, anaplastic lymphoma kinase; CNG, copy number gain; IHC, immunohistochemical staining; ER, estrogen receptor; PR, progesterone receptor; HER2, human epidermal growth factor receptor 2; TNBC, triple-negative breast cancer.</p><p><sup>a</sup>ALK gene copy number status according to the frequency of tumor cells with specific numbers of copies in fluorescence <i>in situ</i> hybridization.</p><p><sup>b</sup>ALK IHC score according to the proportion of stained cells to total analyzed cells</p><p>Comparison of ALK Immunohistochemical staining and fluorescence <i>in situ</i> hybridization analysis results. (n = 27).</p
Biological Sciences, copy number change, ALK expression status, ihc, hr, rfs, IBC patients.MethodsWe retrospectively, er, ALK copy number gain, IBC patients, anaplastic lymphoma kinase, Anaplastic Lymphoma Kinase Gene Copy Number Gain, ci, her, Prognostic Implication BackgroundInflammatory breast cancer, ALK gene amplification, ALK gene copy number change, Inflammatory Breast Cancer, ALK CNG
DOI identifier: 10.1371/journal.pone.0120320.t002
Sorry, we are unable to provide the full text but you may find it at the